CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gordon James who wrote (243)	8/20/1999 4:03:00 PM
From: Gordon James	Read Replies (1) of 666

P.S. Re: my speculation about the Bexxar/fludarabine trial being at Fred Hutchinson - now that I think of it, that's unlikely unless the protocol is myeloablative+BMT/stem cell rescue, I think that's the specialty there. There is a first-line trial mentioned on the Coulter website, but I had understood it was a single-agent protocol, that's where I may be mistaken... GJ

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next